Table of Content 1 Industry Overview 1.1 Biologics and Biosimilars Industry 1.1.1 Overview 1.1.2 Development of Biologics and Biosimilars 1.2 Market Segment 1.2.1 By Product Type 1.2.2 By Application 1.3 Asia-Pacific Overview 2 Major Companies List 2.1 Roche (Company Profile, Products & Services, Sales Data etc.) 2.2 Amgen (Company Profile, Products & Services, Sales Data etc.) 2.3 AbbVie (Company Profile, Products & Services, Sales Data etc.) 2.4 Sanofi-Aventis (Company Profile, Products & Services, Sales Data etc.) 2.5 Johnson & Johnson (Company Profile, Products & Services, Sales Data etc.) 2.6 Pfizer (Company Profile, Products & Services, Sales Data etc.) 2.7 Novo Nordisk (Company Profile, Products & Services, Sales Data etc.) 2.8 Eli Lilly (Company Profile, Products & Services, Sales Data etc.) 2.9 Novartis (Company Profile, Products & Services, Sales Data etc.) 2.10 Merck (Company Profile, Products & Services, Sales Data etc.) 2.11 3sbio (Company Profile, Products & Services, Sales Data etc.) 2.12 Changchun High Tech (Company Profile, Products & Services, Sales Data etc.) 2.13 CP Guojian (Company Profile, Products & Services, Sales Data etc.) 2.14 Biotech (Company Profile, Products & Services, Sales Data etc.) 2.15 Gelgen (Company Profile, Products & Services, Sales Data etc.) 2.16 Innovent (Company Profile, Products & Services, Sales Data etc.) 2.17 Dong Bao (Company Profile, Products & Services, Sales Data etc.) 2.18 Ganlee (Company Profile, Products & Services, Sales Data etc.) 2.19 United Laboratories (Company Profile, Products & Services, Sales Data etc.) 3 Market Competition 3.1 Company Competition 3.2 Regional Market by Company 4 Biologics and Biosimilars Market by Type 4.1 By Type 4.1.1 Antibody 4.1.2 Hormone 4.1.3 Growth Factors 4.1.4 Others 4.2 Market Size 4.3 Market Forecast 5 Market Demand 5.1 Demand Situation 5.1.1 Demand in Tumor 5.1.2 Demand in Diabetes 5.1.3 Demand in Cardiovascular 5.1.4 Demand in Hemophilia 5.1.5 Demand in Others 5.2 Regional Demand Comparison 5.3 Demand Forecast 6 Region Operation 6.1 Regional Production 6.2 Regional Market 6.3 by Region 6.3.1 China 6.3.1.1 By Type 6.3.1.2 By Application 6.3.2 Japan & Korea 6.3.2.1 By Type 6.3.2.2 By Application 6.3.3 India 6.3.3.1 By Type 6.3.3.2 By Application 6.3.4 Southeast Asia 6.3.4.1 By Type 6.3.4.2 By Application 6.3.5 Oceania 6.3.5.1 By Type 6.3.5.2 By Application 6.4 Regional Forecast 7 Marketing & Price 7.1 Price and Margin 7.1.1 Price Trends 7.1.2 Factors of Price Change 7.1.3 Manufacturers Gross Margin Analysis 7.2 Marketing Channel 8 Upstream & Cost 8.1 Upstream 8.2 Cost 9 Industry Environment 9.1 Policy 9.2 Economics 9.3 Sociology 9.4 Technology 10 Research Conclusion

Table Product Segment of Biologics and Biosimilars Table Asia-Pacific Biologics and Biosimilars Market 2012-2023, by Product Type, in USD Million Table Application Segment of Biologics and Biosimilars Table Asia-Pacific Biologics and Biosimilars Market 2012-2023, by Application, in USD Million Table Roche Overview List Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Cost, Gross Margin) Table Amgen Overview List Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Cost, Gross Margin) Table AbbVie Overview List Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Cost, Gross Margin) Table Sanofi-Aventis Overview List Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Cost, Gross Margin) Table Johnson & Johnson Overview List Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin) Table Pfizer Overview List Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin) Table Novo Nordisk Overview List Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Cost, Gross Margin) Table Eli Lilly Overview List Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin) Table Novartis Overview List Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Cost, Gross Margin) Table Merck Overview List Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Cost, Gross Margin) Table 3sbio Overview List Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Cost, Gross Margin) Table Changchun High Tech Overview List Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin) Table CP Guojian Overview List Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Cost, Gross Margin) Table Biotech Overview List Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Cost, Gross Margin) Table Gelgen Overview List Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin) Table Innovent Overview List Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Cost, Gross Margin) Table Dong Bao Overview List Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin) Table Ganlee Overview List Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin) Table United Laboratories Overview List Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin) Table Asia-Pacific Biologics and Biosimilars Sales Revenue 2012-2017, by Company, in USD Million Table Asia-Pacific Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million Table Major Company List of Antibody Table Major Company List of Hormone Table Major Company List of Growth Factors Table Major Company List of Others Table Asia-Pacific Biologics and Biosimilars Market 2012-2017, by Type, in USD Million Table Asia-Pacific Biologics and Biosimilars Market Forecast 2018-2023, by Type, in USD Million Table Biologics and Biosimilars Demand in Tumor, 2012-2017, in USD Million Table Major Consumers in Tumor Table Biologics and Biosimilars Demand in Diabetes, 2012-2017, in USD Million Table Major Consumers in Diabetes Table Biologics and Biosimilars Demand in Cardiovascular, 2012-2017, in USD Million Table Major Consumers in Cardiovascular Table Biologics and Biosimilars Demand in Hemophilia, 2012-2017, in USD Million Table Major Consumers in Hemophilia Table Biologics and Biosimilars Demand in Others, 2012-2017, in USD Million Table Major Consumers in Others Table Regional Demand Comparison List Table Major Application in Different Regions Table Biologics and Biosimilars Demand Forecast 2018-2023, by Application, in USD Million Table Biologics and Biosimilars Production 2012-2017, by Region, in USD Million Table Asia-Pacific Biologics and Biosimilars Market Size 2012-2017, by Region, in USD Million Table China Biologics and Biosimilars Market Size 2012-2017, by Type, in USD Million Table China Biologics and Biosimilars Market Size 2012-2017, by Type, in Table China Biologics and Biosimilars Market Size 2012-2017, by Application, in USD Million Table China Biologics and Biosimilars Market Size 2012-2017, by Application, in Table Japan & Korea Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Japan Biologics and Biosimilars Market Size 2012-2017, by Type, in USD Million Table Japan Biologics and Biosimilars Market Size 2012-2017, by Type, in Table Japan Biologics and Biosimilars Market Size 2012-2017, by Application, in USD Million Table Japan Biologics and Biosimilars Market Size 2012-2017, by Application, in Table India Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table India Biologics and Biosimilars Market Size 2012-2017, by Type, in USD Million Table India Biologics and Biosimilars Market Size 2012-2017, by Type, in Table India Biologics and Biosimilars Market Size 2012-2017, by Application, in USD Million Table India Biologics and Biosimilars Market Size 2012-2017, by Application, in Table Southeast Asia Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Southeast Asia Biologics and Biosimilars Market Size 2012-2017, by Type, in USD Million Table Southeast Asia Biologics and Biosimilars Market Size 2012-2017, by Type, in Table Southeast Asia Biologics and Biosimilars Market Size 2012-2017, by Application, in USD Million Table Southeast Asia Biologics and Biosimilars Market Size 2012-2017, by Application, in Table Oceania Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Oceania Biologics and Biosimilars Market Size 2012-2017, by Type, in USD Million Table Oceania Biologics and Biosimilars Market Size 2012-2017, by Type, in Table Oceania Biologics and Biosimilars Market Size 2012-2017, by Application, in USD Million Table Oceania Biologics and Biosimilars Market Size 2012-2017, by Application, in Table Biologics and Biosimilars Market Forecast 2018-2023, by Region, in USD Million Table Price Factors List Table Upstream Segment of Biologics and Biosimilars Figure Biologics and Biosimilars Industry Chain Structure Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth Rate 2012-2023 Figure China Biologics and Biosimilars Market, by Company, in 2018 Figure Japan & Korea Biologics and Biosimilars Market, by Company, in 2018 Figure India Biologics and Biosimilars Market, by Company, in 2018 Figure Southeast Asia Biologics and Biosimilars Market, by Company, in 2018 Figure Oceania Biologics and Biosimilars Market, by Company, in 2018 Figure Asia-Pacific Biologics and Biosimilars Market Growth 2012-2017, by Type, in USD Million Figure China Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Japan & Korea Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure India Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Southeast Asia Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Oceania Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Marketing Channels Overview